Restless legs syndrome
Restless legs syndrome (RLS) is a treatable sleep disorder causing leg discomfort and an irresistible urge to move the legs. Treatment includes lifestyle changes, iron therapy for low iron levels, and medications like dopamine agonists or alpha-2-delta calcium channel ligands. Augmentation, a worsening of symptoms with medication, can be managed by adjusting treatment. Refractory cases may require combining medications or using low-dose opioids. Treatment should be tailored to the individual, with careful monitoring for effectiveness and side effects.
Nocturnal enuresis
Nocturnal enuresis (NE) refers to bedwetting in adults, often associated with various medical conditions and medications. It can lead to psychological distress. Treatment options include addressing underlying medical issues, lifestyle changes (avoiding certain substances, weight management, regular exercise), behavioral therapy (timed voiding, alarm systems, adapted dry behavioral therapy), and medications like desmopressin or imipramine. For resistant cases, neuromodulation or botulinum toxin injections may be considered after other modalities have failed.
Sleep related hallucinations
Hypnagogic and hypnopompic hallucinations are vivid sensory experiences occurring during sleep transitions. They can be linked to various conditions and medications. Treatment primarily addresses daytime sleepiness and cataplexy, which can indirectly improve hallucinations. Non-pharmacological approaches include sleep hygiene and napping. Medications like modafinil, armodafinil, solriamfetol, and others are used to manage symptoms, while REM sleep-suppressing drugs like venlafaxine or sodium oxybate may also be considered.
Recurrent isolated sleep paralysis
Recurrent isolated sleep paralysis (RISP) involves temporary immobility and hallucinations during sleep transitions. It affects about 20% of young adults, often linked to anxiety or sleep deprivation. Treatment includes education, sleep hygiene, and cognitive-behavioral therapy (CBT). Tricyclic antidepressants or selective serotonin reuptake inhibitors can be used to reduce episodes.
Rapid Eye Movement
Rapid Eye Movement (REM) sleep behavior disorder (RBD) involves acting out dreams during REM sleep and is associated with potential injury to oneself or a bed partner. It is often a precursor to neurodegenerative conditions like Parkinson's disease. Treatment focuses on creating a safe sleeping environment, which can include behavioral modifications such as separate beds or rooms and removing potential hazards. Medications like melatonin or clonazepam may be prescribed when necessary, especially in cases with frequent or disruptive behaviors that pose a risk.
Nightmare disorder
Nightmares, often triggered by stress or trauma, can disrupt daily life. Lifestyle adjustments, such as emotional well-being, avoiding specific substances before bedtime, and maintaining a regular sleep schedule, can alleviate symptoms. Psychotherapy, particularly imagery rehearsal therapy (IRT), is effective for managing recurring nightmares by rewriting and rehearsing them to make them less distressing. When medication is needed, prazosin, an alpha-1 adrenergic receptor antagonist, is a common choice.
Sleep terrors
Sleep terrors involve sudden sitting up in bed, screaming, and sometimes walking around during non-REM sleep. They typically happen early in the night and can last for a few minutes to 40 minutes. These episodes are often associated with increased sympathetic nervous system activity and may be seen in individuals with psychiatric conditions like PTSD or anxiety. Treatment includes behavioral strategies like avoiding sleep deprivation and alcohol, as well as educating family members on how to safely interact during episodes. In severe cases, medications like clonazepam may be used.
Sleepwalking (somnambulism)
Sleepwalking (somnambulism) involves complex behaviors like walking or rearranging furniture during sleep, often with amnesia. Prevention includes maintaining regular sleep schedules, a safe sleep environment, and sometimes cognitive-behavioral therapy. Medications like clonazepam or melatonin are reserved for severe cases. Safety education is essential to avoid injury during episodes.
Advanced sleep-wake phase disorder
Advanced sleep-wake phase disorder (ASWPD) causes early sleep onset and wake times, resulting in daytime sleepiness. Evening bright light therapy, where patients sit near a bright light for 1-3 hours, is the main treatment. Behavioral methods like chronotherapy can help. Melatonin might be considered but lacks strong evidence, while hypnotics for early morning awakening should be avoided due to potential daytime drowsiness.
Delayed sleep-wake phase disorder
Delayed sleep-wake phase disorder (DSWPD) is common in adolescents, causing them to stay up and wake later than desired, often leading to difficulties in daily life. Comorbid depression is also frequent. Treatment mainly involves behavioral changes, like gradually adjusting bedtime and wake time, improving sleep hygiene, and avoiding stimulants before sleep. In cases where these don't work, timed melatonin or light therapy may help realign the circadian rhythm. Melatonin (3 mg before bedtime) can be tried, and morning light exposure can be used to shift the circadian rhythm earlier. It's crucial for patients to follow these therapies consistently.
Idiopathic
Idiopathic hypersomnia causes chronic excessive daytime sleepiness and difficulty waking up. Diagnosis requires polysomnography to rule out other causes. Treatment focuses on symptom management. Non-pharmacological approaches like lifestyle advice and behavioral modification are recommended, but they may not be very effective. Medications like modafinil, armodafinil, or methylphenidate can help control sleepiness, but patients should be cautious with activities like driving. Regular follow-ups every six months are important to monitor medication effects and overall well-being.
Narcolepsy
Narcolepsy is characterized by daytime sleepiness, cataplexy, hallucinations, and sleep paralysis. Diagnosis involves sleep tests. Treatment may include non-pharmacological measures like sleep hygiene and support groups. Medications like modafinil, armodafinil, solriamfetol, pitolisant, or stimulants can help with daytime sleepiness. Cataplexy may require drugs like venlafaxine or sodium oxybate. Patients should also be screened for depression and treated if necessary.
Obstructive sleep apnea
Obstructive sleep apnea (OSA) is common in obese men and characterized by symptoms like snoring and gasping during sleep. Diagnosis is confirmed through polysomnography. Treatment includes behavioral changes, such as weight loss and positional adjustments, and positive airway pressure therapy like CPAP. In severe cases, oral appliances or surgery may be considered. Patients should also be aware of the risks associated with untreated OSA, including daytime sleepiness and an increased risk of accidents.
Insomnia
Insomnia can occur due to multiple factors, both short-term and chronic. Short-term cases may require short-term medication, while chronic insomnia can be managed with Cognitive and Behavioral Therapy (CBT) or medication like zolpidem. Tapering medication and addressing sleep expectations are crucial. CBT includes behavioral and cognitive components, and medication choice varies. Efforts to discontinue sedative medications and reinforce healthy sleep habits through CBT are essential for long-term management.